Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-767P is a **pseudogene** related to the U6 small nuclear RNA (snRNA) family. The U6 snRNA, a component of the spliceosomal machinery, is critical for pre-mRNA splicing[1][3]. Unlike canonical U6 snRNA genes, pseudogenes like RNU6-767P are considered non-functional genomic sequences derived from genuine U6 snRNA genes and do not produce active RNA molecules involved in spliceosome assembly or function[5]. Multiple U6 snRNA pseudogenes are common in vertebrate genomes, likely representing evolutionary remnants with no known biological activity[3][5]. Because RNU6-767P is a pseudogene—not a protein, enzyme, receptor, or other typical drug target—it is not classified as a therapeutic target and has no established function in disease, drug interaction, or biomarker relevance[5][1][3]. The entry appears mainly as a product of genome annotation with no evidence of being a target or having any therapeutic utility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 767, pseudogene (RNU6-767P).